Narrow search
Showing 1 - 10 of 1,841
Cover Image
Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?
Cook, Amanda C.; Sirmans, E. Tice; Wells, Brenda - In: The Geneva papers on risk and insurance - issues and … 49 (2024) 1, pp. 212-226
Persistent link: https://www.econbiz.de/10014446859
Cover Image
Should pharmaceutical costs be curbed?
Brekke, Kurt R.; Dalen, Dag Morten; Strøm, Steinar - In: Nordic economic policy review (2012) 2, pp. 247-273
Persistent link: https://www.econbiz.de/10010379568
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …
Persistent link: https://www.econbiz.de/10012291135
Cover Image
U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016
Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26
Persistent link: https://www.econbiz.de/10012182277
Cover Image
Paying for pharmaceuticals : uniform pricing versus two-part tariffs
Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune - In: Journal of health economics 83 (2022), pp. 1-21
Persistent link: https://www.econbiz.de/10013350399
Cover Image
The economics of alternative payment models for pharmaceuticals
Hlávka, Jakub P.; Yu, Jeffrey C.; Goldman, Dana P.; … - In: The European journal of health economics 22 (2021) 4, pp. 559-569
Persistent link: https://www.econbiz.de/10012586512
Cover Image
The impact of race, income, drug abuse and dependence on health insurance coverage among US adults
Wang, Nianyang; Xie, Xin - In: The European journal of health economics : HEPAC ; … 18 (2017) 5, pp. 537-546
Persistent link: https://www.econbiz.de/10011868688
Cover Image
Measuring access to health care services
Roll, Kathrin - 2012
Persistent link: https://www.econbiz.de/10009711603
Cover Image
Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan
Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275
Persistent link: https://www.econbiz.de/10010345585
Cover Image
Pharma-Daten
Berlin : BPI; anfangs: Frankfurt, M. : BPI - Nachgewiesen 1972 - 1974; 5.1975 -
Persistent link: https://www.econbiz.de/10000363330